Report center

医药行业2023年三季度总结报告:医疗反腐影响逐渐消除,血制品、疫苗、中药持续稳健-20231105-东吴证券

➢ 医药行业:2023年前三季度405家医药上市公司收入总额同比增速为5.63%、归母净利润总额同比增速达5.36%、扣非归母净利润总额同比增速达5.5%。2023Q3季度405家医药上市公司收入总额同比下滑1.6%、归母净利润总额同比增速为0.9%、扣非归母净利润总额同比下滑2.1%。单Q3收入及扣非归母净利润均环比Q2有所下滑,主要系受院内政策影响。分季度来看,Q1季度收入同比增速最快,Q2、

No subject companies

Publishers

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

  1. 1东吴证券Published by or linked to this institution1
  2. 2CXO & Pharma Supply ChainSame industry · 1 related reports1
  3. 3International Expansion PlaybookSame industry · 1 related reports1
  4. 4Public Investment as a Catalyst: Crowding in Private Capital in Europe and Central AsiaSame industry · 1 related reports1

Other hot industries

Similar reports

← Back to knowledge graph